TRAXIVITUG

UNII:	V5T95AZA8Y
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	TRAXIVITUG
GSRS Full Record:	V5T95AZA8Y i

2770852-89-4
Gamma1 heavy chain Homo sapiens (1-450) [VH(Homo sapiens IGHV3-7*01 (89.7%) -(IGHD) -IGHJ5*01 (85.7%)) [8.8.13] (26-33.51-58.97-109) (1-120) -Homo sapiens IGHG1*03, G1m3, nG1m1 CH1R120, E12, M14 (CH1 R120 (217) (121-218), hinge 1-15 (219-233), CH2 (234-343), CH3 CH3 E12 (359), M14 (361) (344-448), CHS (449-450)) (121-450)], (223-212')-disulfide with lambda2 light chain Homo sapiens (1'-213') [V-LAMBDA (Homo sapiens IGLV3-21*03 (92.6%) -IGLJ2*01 (90,0%) L124>V (104))[6.3.10] (26'-31'.49'-51'.88'-97') (1'-107') -Homo sapiens IGLC2*01 (100%) (108'-213')]
Immunoglobulin G1, anti-(BK virus viral capsid protein VP1) (human monoclonal MAU868 γ1-chain), disulfide with human monoclonal MAU868 λ-chain, dimer
Immunoglobulin G1-lambda2, anti-[BK polyomavirus (BKV) major capsid protein VP1], Homo sapiens monoclonal antibody
MAU-868
MAU868
TRAXIVITUG [USAN]
Traxivitug
traxivitug [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TRAXIVITUG

Synonyms and Mappings

Resources